Cargando…
Diabetes and dyslipidemia: characterizing lipoprotein metabolism
Premature atherosclerosis in diabetes accounts for much of the decreased life span. New treatments have reduced this risk considerably. This review explores the relationship among the disturbances in glucose, lipid, and bile salt metabolic pathways that occur in diabetes. In particular, excess nutri...
Autores principales: | Tomkin, GH, Owens, D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546776/ https://www.ncbi.nlm.nih.gov/pubmed/28814891 http://dx.doi.org/10.2147/DMSO.S115855 |
Ejemplares similares
-
Commentary on High-density Lipoprotein Versus Low-density Lipoprotein Therapy and Cardiovascular Outcomes in Patients with Acute Coronary Syndromes by Nikolaos Papageorgiou et al.
por: Owens, D.A., et al.
Publicado: (2018) -
Angiopoietin-Like Protein 3 (ANGPTL3) Modulates Lipoprotein Metabolism and Dyslipidemia
por: Chen, Pei-Yi, et al.
Publicado: (2021) -
Dyslipidemia: Genetics, lipoprotein lipase and HindIII polymorphism
por: Palacio Rojas, Marcos, et al.
Publicado: (2018) -
Nutrigenetic Contributions to Dyslipidemia: A Focus on Physiologically Relevant Pathways of Lipid and Lipoprotein Metabolism
por: Hannon, Bridget A., et al.
Publicado: (2018) -
The Chylomicron: Relationship to Atherosclerosis
por: Tomkin, Gerald H., et al.
Publicado: (2012)